Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 393-400 , May 2008

[64Cu]diacetyl-bis(N4-methyl-thiosemicarbazone) — a radiotracer for tumor hypoxia

  • Katie A. Wood

      Affiliations

    • Gray Cancer Institute, Northwood, Middlesex
    • Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex
    • University College Hospital, London
    • Corresponding Author InformationCorresponding author. Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN, UK. Tel.: +44 1923818611x4533; fax: +44 1923844167.
    • ,
  • Wai Lup Wong

      Affiliations

    • Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex
    • ,
  • Michele I. Saunders

      Affiliations

    • Gray Cancer Institute, Northwood, Middlesex
    • Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex
    • University College Hospital, London

Received 29 November 2007 ,Revised 4 February 2008 ,Accepted 6 February 2008.

References 

  1. Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govidan R, Laforest R. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. Eur J Nucl Med Mol Imaging. 2003;30(6):844–850
  2. Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys. 2003;55(5):1233–1238
  3. Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ. Assessing tumour hypoxia in cervical cancer by PET with [60Cu]-labeled diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2008;49(2):201–205
  4. Apisarnthanarax S, Chao KS. Current imaging paradigms in radiation oncology. Radiat Res. 2005;163(1):1–25
  5. Fujibayashi Y, Matsumoto K, Arano Y, Yonekura Y, Konishi J, Yokoyama A. 62Cu-labelling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator system. Chem Pharm Bull. 1990;38:1946
  6. Baerga ID, Maickel RP, Green MA. Subcellular distribution of tissue radiocopper following intravenous administration of [67Cu]-labelled Cu-PTSM. Nucl Med Biol. 1992;19(6):697–701
  7. Anderson CJ, Rocque PA, Weinheimer CJ, Welch MJ. Evaluation of copper-labelled bifunctional chelate–albumin conjugates for blood pool imaging. Nucl Med Biol. 1993;20(4):461–467
  8. Fujibayashi Y, Wada K, Taniuchi H, Yonekura Y, Konishi J, Yokoyama A. Biol Pharm Bull. 1993;16(2):146–149
  9. Castle TC, Maurer RI, Sowrey FE, Went MJ, Reynolds CA, McInnes EJ, et al. Hypoxia-targeting copper bis(selenosemicarbazone) complexes: comparison with their sulfur analogues. J Am Chem Soc. 2003;125(33):10040–10049
  10. Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med. 1997;38(7):1155–1160
  11. Lewis JL, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumour model. J Nuc Med. 1999;(40):177–183
  12. Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med. 2001;42(4):655–661
  13. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;(23):957–980
  14. Vavere AL, Lewis JS. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. Dalton Trans. 2007;(43):4983–5902
  15. Dearling JLJ, Lewis JS, McCarthy DW, Welch MJ, Blower PJ. Redox-active metal complexes for imaging hypoxic tissues: structure–activity relationships in copper(II) bis(thiosemicarbazone) complexes. Chem Commun. 1998;2531–2532
  16. Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2006;47(6):989–998
  17. Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]fluoromisonidazole positron emission tomography. Int J Oncol. 2007;30(4):873–881
  18. Laforest R, Dehdashti F, Lewis JS, Schwarz SW. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging. 2005;32(7):764–770
  19. Dearling JLJ, Lewis JS, Mullen GED, Welch MJ, Blower PJ. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure–activity relationships. J Biol Inorg Chem. 2002;7:249–259
  20. Burgman P, O'Donoghue JA, Lewis JS, Welch MJ, Humm JL, Ling C. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Nucl Med Biol. 2005;32:623–630
  21. Harris E. Copper homeostasis: the role of cellular transporters. Nutr Rev. 2001;59:281–285
  22. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, Howell SB. The copper export pump nATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol. 2003;64:466–473
  23. Fujibayashi Y, Cutler CS, Anderson CJ, McCarthy DW, Jones LA, Sharp T, et al. Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol. 1999;26:117–121
  24. Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). J Nucl Med. 2002;43(11):1557–1569
  25. Lewis J, Laforest R, Buettner T, Song S, Fujibayashi Y, Connett J. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): an agent for radiotherapy. Proc Natl Acad Sci U S A. 2001;98(3):1206–1211
  26. O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones , Cai S. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys. 2005;61(5):1493–1502
  27. Schroeder T, Yuan H, Viglianti BL, Peltz C, Asopa S, Vujaskovic Z. Saptial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res. 2005;(65):5163–5171
  28. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49(4):1171–1182
  29. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41(1):31–39
  30. Saunders M. Use of 64Cu-ATSM for identifying tumour hypoxia in squamous cell carcinoma of the head and neck. London: UCL and Mount Vernon Hospital; 2007;

PII: S0969-8051(08)00034-6

doi: 10.1016/j.nucmedbio.2008.02.002

Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 393-400 , May 2008

Article Tools

* Image Usage & Resolution